WHO /
The Ministry of Health of Saudi Arabia has issued the following
requirements and recommendations for entry visas for the Hajj and Umra
seasons in 2012.
Yellow Fever
In accordance with the International Health Regulations 2005, all travellers arriving from countries or areas at risk of yellow fever must present a valid yellow fever vaccination certificate showing that the person was vaccinated at least 10 days previously and not more than 10 years before arrival at the border. In the absence of such a certificate, the individual will be placed under strict surveillance for 6 days from the date of vaccination or the last date of potential exposure to infection, whichever is earlier.
Meningococcal meningitis
For all arrivals
Visitors from all over the world arriving for the
purpose of Umra or pilgrimage or for seasonal work are required to
produce a certificate of vaccination with the quadrivalent (ACYW135)
vaccine against meningitis issued not more than 3 years previously and
not less than 10 days before arrival in Saudi Arabia. The responsible
authorities in the visitor’s country of origin should ensure that adults
and children over the age of 2 years are given 1 dose of the
quadrivalent polysaccharide (ACYW135) vaccine.
For arrivals from countries in the African meningitis belt, namely Benin, Burkina Faso, Cameroon, Chad, Central African Republic, Côte d’Ivoire, Eritrea, Ethiopia, Gambia, Guinea, Guinea-Bissau, Mali, Niger, Nigeria, Senegal and Sudan.In addition to the above stated requirements, chemoprophylaxis will be administered at port of entry to all arrivals from these countries to lower the carriers rate among them. Adults will receive ciprofloxacin tablets(500 mg), children will receive rifampicin, and pregnant women will receive ceftriaxone injections.
For arrivals from countries in the African meningitis belt, namely Benin, Burkina Faso, Cameroon, Chad, Central African Republic, Côte d’Ivoire, Eritrea, Ethiopia, Gambia, Guinea, Guinea-Bissau, Mali, Niger, Nigeria, Senegal and Sudan.In addition to the above stated requirements, chemoprophylaxis will be administered at port of entry to all arrivals from these countries to lower the carriers rate among them. Adults will receive ciprofloxacin tablets(500 mg), children will receive rifampicin, and pregnant women will receive ceftriaxone injections.
Poliomyelitis
All travellers arriving from polio-endemic countries and re-established transmission countries,
namely Afghanistan, Angola, Chad, the Democratic Republic of Congo,
Nigeria and Pakistan, regardless of age and vaccination status, should
receive 1 dose of oral poliovirus vaccine (OPV). Proof of OPV
vaccination at least 6 weeks prior departure is required to apply for
entry visa for Saudi Arabia. These travellers will also receive 1 dose
of OPV at borders points on arrival in Saudi Arabia. The same
requirements are valid for travellers from recently endemic countries at
high risk of reimportation of poliovirus, i.e. India.
All visitors aged under 15 years travelling to Saudi Arabia from countries with imported cases of poliomyelitis
or circulating vaccine-derived polioviruses (see list below) in the
past 12 months (as of mid-February 2012) should be vaccinated against
poliomyelitis with the OPV or inactivated poliovirus vaccine (IPV).
Proof of OPV or IPV vaccination is required 6 weeks prior the
application for entry visa. Irrespective of previous immunization
history, all visitors under 15 years arriving in Saudi Arabia will also
receive 1 dose of OPV at border points.
Polio cases related to wild poliovirus importation or to
circulating vaccine-derived poliovirus have been registered during the
past 12 months in the following countries: China, Central African
Republic, Côte d’Ivoire, Kenya, Mali, Niger, Somalia and Yemen.
Seasonal influenza
The Ministry of Health of Saudi Arabia recommends that
international pilgrims be vaccinated against seasonal influenza before
arrival into the kingdom of Saudi Arabia, particularly those at
increased risk of severe complications (e.g. the elderly over 65 years
of age, people with pre-existing medical conditions such as people with
chronic respiratory or heart diseases, hepatic or renal failure,
neuromuscular or metabolic diseases including diabetes or
immunocompromised conditions due to various reasons such as HIV
infection or immunosuppressive therapy). Pregnant women can also be
considered for vaccination.
In Saudi Arabia, seasonal influenza vaccine is
recommended for internal pilgrims, particularly those with pre-existing
health conditions, and all health staff working in the Hajj premises.
International outbreaks response
Updating immunization against vaccine-preventable diseases in all
travellers is strongly recommended. With the recent resurgence of
measles and rubella cases, special attention is needed for both of these
vaccines to avoid widespread outbreaks with this virus during this year
Hajj and Umra.
Preparation for international travel provides opportunity to review the immunization status of travellers. Incompletely immunized travellers can be offered routine vaccinations recommended in national immunization schedules (these usually include diphtheria, tetanus, pertussis, polio, measles and mumps), in addition to those needed for the specific travel (e.g. meningococcal vaccination for Hajj).
In InternationalTravel and Health 2012, WHO recommends that travelers ensure immunity against measles by having at least 2 doses of vaccine and against rubella by 1 dose of vaccine.
Preparation for international travel provides opportunity to review the immunization status of travellers. Incompletely immunized travellers can be offered routine vaccinations recommended in national immunization schedules (these usually include diphtheria, tetanus, pertussis, polio, measles and mumps), in addition to those needed for the specific travel (e.g. meningococcal vaccination for Hajj).
In InternationalTravel and Health 2012, WHO recommends that travelers ensure immunity against measles by having at least 2 doses of vaccine and against rubella by 1 dose of vaccine.